Focus:
M&As
-
2 September 2019
Takeda-Shire deal: the strategy behind Japan’s largest foreign acquisition
Within a year of Japan’s Takeda expressing its interest in buying Shire, the deal had been approved by all necessary regulatory authorities and both companies’ shareholders; allowing Shire’s integration into...
-
23 August 2019
US pharma industry sees a drop of 22.2% in deal activity in July 2019
The US pharma industry saw a drop of 22.2% in overall deal activity during July 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this...
-
21 August 2019
Pharma industry deals in July 2019 total $4.57bn globally
Total pharma industry deals for July 2019 worth $4.57bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
-
16 July 2019
China’s pharma industry sees a drop of 28.1% in deal activity in Q2 2019
China's pharma industry saw a drop of 28.1% in overall deal activity during Q2 2019, when compared with the last four-quarter average, according to GlobalData's deals database. Embed this chart...
-
16 July 2019
North America’s pharma industry sees a drop of 10.3% in deal activity in Q2 2019
North America's pharma industry saw a drop of 10.3% in overall deal activity during Q2 2019, when compared to the four-quarter average, according to GlobalData's deals database. Embed this chart...
-
16 July 2019
Europe’s pharma industry sees a rise of 1.2% in deal activity in Q2 2019
Europe's pharma industry saw a rise of 1.2% in overall deal activity during Q2 2019, when compared to the four-quarter average, according to GlobalData's deals database. Embed this chart Embed...
-
16 July 2019
Pharma industry M&A deals in Q2 2019 total $114.8bn globally
Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste...
-
16 July 2019
Pharma industry deals in Q2 2019 total $121.51bn globally
Total pharma industry deals for Q2 2019 worth $121.51bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
-
16 July 2019
Pharma industry M&A deals in Q2 2019 total $19.5bn in US
Total pharma industry M&A deals in Q2 2019 worth $19.5bn were announced in the US, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy...
-
16 July 2019
Pharma industry deals in June 2019 total $102.8bn globally
Total pharma industry deals for June 2019 worth $102.8bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...